Marksans Pharma informs about board meeting

08 May 2025 Evaluate
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) and other regulations, if applicable, Marksans Pharma has informed that a meeting of the Board of Directors of the Company will be held on Monday, May 19, 2025 at Mumbai, to transact the following businesses: 1. To consider and approve the Audited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and Year ended March 31, 2025. 2. To consider recommendation of dividend on the equity shares for the financial year 2024- 25, if any. As per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Company’s Internal Code on Prohibition of Insider Trading, the Trading Window for dealing in Company’s shares has been closed for the Company’s Designated Persons (including Directors) and their immediate relatives from April 01, 2025 and will remain closed till Forty-Eight hours after the announcement of the Financial Results i.e. up to May 21, 2025. Further, as per the Listing Regulations, this intimation of the Board Meeting would be available on the website of the Company: www.marksanspharma.com, BSE: www.bseindia.com and National Stock Exchange of India: www.nseindia.com. 

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×